A “Space-for-Time” Strategy Based on Single-Cell Dual-Isotope ICP-MS Analysis Enabling High-Throughput and Sensitive Quantification of miRNAs in Breast Cancer Cells for Therapeutic Assessment
- 27 August 2025
- journal article
- Published by American Chemical Society (ACS) in Analytical Chemistry
Abstract
MiRNAs regulate cancer progression and serve as both biomarkers and therapeutic targets in chemotherapy and gene therapy. Current analytical platforms lack the capacity to concurrently satisfy single-cell resolution and target specificity while maintaining high-throughput performance and cost-effectiveness. This limitation underscores the critical demand for innovative precision detection technologies. In this study, we focused on two key regulatory miRNAs in breast cancer therapeutic assessment and developed a "space-for-time" strategy using dual-isotope ICP-MS for single-cell miRNAs quantification. The spatial expansion of analytes via single hydrogel microbead encapsulation and collision gas utilization significantly prolonged single-particle ion cloud duration, overcoming the limitations of traditional quadrupole mass spectrometry in the precise dual-isotope quantification. A custom-designed microfluidic chip integrating droplet generation and inertial focusing achieved a single-cell encapsulation efficiency of 57%, thereby enabling a high throughput of ∼1000 cells/min in ICP-MS. In-bead rolling circle amplification combined with nanoprobe labeling enabled femtomolar-level sensitivity for miR-21 and miR-10b detection. This platform facilitated high-throughput, quantitative profiling of miRNA expression across various breast cancer subtypes and offered enhanced resolution of therapeutic responses. In chemotherapy monitoring, our approach revealed early molecular signatures of apoptosis/invasion, outperforming traditional viability and invasion assays in sensitivity and timeliness. For gene therapy evaluation, the platform uncovered subtype-specific differences in miRNA inhibition at single-cell resolution, highlighting tumor heterogeneity thus may potentially guiding precision treatment strategies. Overall, our platform represents a powerful tool for miRNA quantification and therapeutic evaluation, offering robust support for personalized oncology and preclinical drug screening.Keywords
Funding Information
- Natural Science Foundation of Liaoning Province (2024JH3/10200011)
- Fundamental Research Funds for the Central Universities (N2405006, N25QNR010)
- National Natural Science Foundation of China (22074011, 22174011, 22374014)
This publication has 28 references indexed in Scilit:
- High‐Throughput Single‐Cell, Single‐Mitochondrial DNA Assay Using Hydrogel Droplet MicrofluidicsAngewandte Chemie International Edition, 2024
- Recent advances in droplet microfluidics for single-cell analysisTrAC Trends in Analytical Chemistry, 2023
- Exploring the performance of quadrupole, time-of-flight, and multi-collector ICP-MS for dual-isotope detection on single nanoparticles and cellsAnalytica Chimica Acta, 2022
- Targeting out of range biomolecules: Chemical labeling strategies for qualitative and quantitative MALDI MS-based detectionTrAC Trends in Analytical Chemistry, 2021
- Single-cell metabolomics by mass spectrometry: Advances, challenges, and future applicationsTrAC Trends in Analytical Chemistry, 2019
- On the effect of using collision/reaction cell (CRC) technology in single-particle ICP-mass spectrometry (SP-ICP-MS)Analytica Chimica Acta, 2019
- Determination of the structure and composition of Au-Ag bimetallic spherical nanoparticles using single particle ICP-MS measurements performed with normal and high temporal resolutionTalanta, 2018
- Size-based separation methods of circulating tumor cellsAdvanced Drug Delivery Reviews, 2018
- Hydrogel Droplet Microfluidics for High-Throughput Single Molecule/Cell AnalysisAccounts of Chemical Research, 2016
- Progress in microRNA deliveryJournal of Controlled Release, 2013